I will work with the researchers of GLORY-2 to promote and complete this study, hoping to provide high-quality clinical evidence for weight loss research and bring better treatment options to Chinese patients with moderate to severe obesity." Dr
These effects could explain why researchers are exploring whether the medicines might also benefit conditions such as depression, anxiety, bipolar disorder, and substance use disorders
A majority of people with cardiovascular disease do not have diabetes, adds Ania Jastreboff, MD, PhD, a Yale Medicine endocrinologist, who is an expert in obesity medicine and director of the Yale Obesity Research Center (Y-Weight)
Obesity is increasingly treated as a chronic health condition Healthcare providers across Ohio are shifting how they view and treat obesity
On December 19, 2025, CMS released two proposed rules that would incorporate MFN pricing principles into federal reimbursement for prescription drugs
We are proud to deliver expert IV therapy in a setting that combines clinical excellence with comfort and care
